These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17695713)

  • 21. High-throughput strategies for the discovery and engineering of enzymes for biocatalysis.
    Jacques P; Béchet M; Bigan M; Caly D; Chataigné G; Coutte F; Flahaut C; Heuson E; Leclère V; Lecouturier D; Phalip V; Ravallec R; Dhulster P; Froidevaux R
    Bioprocess Biosyst Eng; 2017 Feb; 40(2):161-180. PubMed ID: 27738757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The production of fine chemicals by biotransformations.
    Straathof AJ; Panke S; Schmid A
    Curr Opin Biotechnol; 2002 Dec; 13(6):548-56. PubMed ID: 12482513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multistep enzyme cascades as a route towards green and sustainable pharmaceutical syntheses.
    Benítez-Mateos AI; Roura Padrosa D; Paradisi F
    Nat Chem; 2022 May; 14(5):489-499. PubMed ID: 35513571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Building blocks.
    Hilterhaus L; Liese A
    Adv Biochem Eng Biotechnol; 2007; 105():133-73. PubMed ID: 17408083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developments in hydrogenation technology for fine-chemical and pharmaceutical applications.
    Machado RM; Heier KR; Broekhuis RR
    Curr Opin Drug Discov Devel; 2001 Nov; 4(6):745-55. PubMed ID: 11899614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New opportunities for biocatalysis: driving the synthesis of chiral chemicals.
    Zheng GW; Xu JH
    Curr Opin Biotechnol; 2011 Dec; 22(6):784-92. PubMed ID: 21783357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating biocatalysis and multicomponent reactions.
    Lambruschini C; Basso A; Banfi L
    Drug Discov Today Technol; 2018 Nov; 29():3-9. PubMed ID: 30471671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Industrial biocatalysis.
    Zaks A
    Curr Opin Chem Biol; 2001 Apr; 5(2):130-6. PubMed ID: 11282338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole organism biocatalysis.
    Ishige T; Honda K; Shimizu S
    Curr Opin Chem Biol; 2005 Apr; 9(2):174-80. PubMed ID: 15811802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Michael acceptors as cysteine protease inhibitors.
    Santos MM; Moreira R
    Mini Rev Med Chem; 2007 Oct; 7(10):1040-50. PubMed ID: 17979807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Commercial scale biocatalysis: myths and realities.
    Rozzell JD
    Bioorg Med Chem; 1999 Oct; 7(10):2253-61. PubMed ID: 10579534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzyme technology and bioprocess engineering.
    Panke S; Wubbolts MG
    Curr Opin Biotechnol; 2002 Apr; 13(2):111-6. PubMed ID: 11950560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Promiscuous De Novo Retro-Aldolase Catalyzes Asymmetric Michael Additions via Schiff Base Intermediates.
    Garrabou X; Beck T; Hilvert D
    Angew Chem Int Ed Engl; 2015 May; 54(19):5609-12. PubMed ID: 25777153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simple and efficient synthesis of substituted 2-pyrrolidinones, 2-pyrrolones, and pyrrolidines from enaminones of Baylis-Hillman derivatives of 3-isoxazolecarbaldehydes.
    Singh V; Saxena R; Batra S
    J Org Chem; 2005 Jan; 70(1):353-6. PubMed ID: 15624948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustainable biocatalytic synthesis of L-homophenylalanine as pharmaceutical drug precursor.
    Ahmad AL; Oh PC; Abd Shukor SR
    Biotechnol Adv; 2009; 27(3):286-96. PubMed ID: 19500550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategic use of preparative chiral chromatography for the synthesis of a preclinical pharmaceutical candidate.
    Leonard WR; Henderson DW; Miller RA; Spencer GA; Sudah OS; Biba M; Welch CJ
    Chirality; 2007 Sep; 19(9):693-700. PubMed ID: 17354260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and use of binary encoded synthetic chemical libraries.
    Baldwin JJ
    Mol Divers; 1996 Oct; 2(1-2):81-8. PubMed ID: 9238637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospects for the increased application of biocatalysts in organic transformations.
    Faber K; Franssen MC
    Trends Biotechnol; 1993 Nov; 11(11):461-70. PubMed ID: 7764400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 4-Hydroxy-5-pyrrolinone-3-carboxamide HIV-1 integrase inhibitors.
    Pace P; Spieser SA; Summa V
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3865-9. PubMed ID: 18595690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breaking the Dogma of Aldolase Specificity: Simple Aliphatic Ketones and Aldehydes are Nucleophiles for Fructose-6-phosphate Aldolase.
    Roldán R; Sanchez-Moreno I; Scheidt T; Hélaine V; Lemaire M; Parella T; Clapés P; Fessner WD; Guérard-Hélaine C
    Chemistry; 2017 Apr; 23(21):5005-5009. PubMed ID: 28266745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.